Popular Articles From: Tokai Pharmaceuticals Announces Updated Phase 2 Data on Galeterone in Patients with Advanced Prostate Cancer to be Presented at the ESMO 2014 Congress to UPDATE: Family Dollar's shares still cushioned by merger hope


Tokai Pharmaceuticals, Inc. (NASDAQ: TKAI), a biopharmaceutical company focused on developing novel therapies for prostate cancer and other hormonally-driven diseases, today announced that updated, interim results from the company’s ongoing Phase 2 clinical trial, ARMOR2, of its lead drug candidate, galeterone, in patients with castration resistant prostate cancer (CRPC) will be presented at the European Society for Medical Oncology (ESMO) 2014 Congress, September 26-30, in Madrid, Spain.
Sign-up for Tokai Pharmaceuticals Announces Updated Phase 2 Data on Galeterone in Patients with Advanced Prostate Cancer to be Presented at the ESMO 2014 Congress investment picks
RALEIGH, N.C., Oct.
Sign-up for Triangle Capital Corporation Invests $21.8 Million in PlayHaven investment picks
DUBLIN, Ohio , Oct.
Sign-up for The Wendy's Company to Report 2014 Third-Quarter Results on November 6 investment picks
2014/9/24
First Burger Works location in Washington, D.C. offers fresh, fire-grilled burgers in a casual, contemporary and friendly dining environment GREENWOOD VILLAGE, Colo.
Sign-up for Red Robin Burger Works to Serve up Burgers Fiery and Fast in Washington, D.C. Beginning October 6 investment picks
Salix Pharmaceuticals, Ltd.
Sign-up for Salix Secures Additional Intellectual Property Relating to Rifaximin investment picks
2014/10/8
CHARLOTTE, N.C. , Oct.
Sign-up for Sixty Duke Energy line technicians to compete for 'best in world' titles at International Lineman's Rodeo Oct. 18 investment picks
Baxter International Inc. (NYSE:BAX) and Halozyme Therapeutics, Inc., (NASDAQ:HALO) today announced the launch and first shipments of HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase], Baxter’s subcutaneous immunoglobulin treatment for adult patients with primary immunodeficiency (PI) in the United States.
Sign-up for Baxter Launches HYQVIA in the United States for Adult Patients with Primary Immunodeficiency investment picks
2014/10/2
Williams-Sonoma will be reopening a retail location and cooking school in Sonoma on October 4th in the same location where the first store opened almost six decades ago.
Sign-up for Williams-Sonoma Re-Opens Store at Original 1956 Sonoma Location investment picks
SEATTLE and SOUTH SAN FRANCISCO, Calif., July 29, 2014 (GLOBE NEWSWIRE) -- Immune Design (Nasdaq:IMDZ) announced today the closing of its initial public offering of 5,000,000 shares, at a public offering price of $12.00 per share, resulting in aggregate gross proceeds of $60.0 million, before underwriting discounts, commissions and expenses.
Sign-up for Immune Design Announces Closing of Initial Public Offering investment picks
2014/10/20
- Series will premiere on City and shomi in Canada, and on Netflix in the rest of the world - TORONTO , Oct.
Sign-up for City, Netflix, and shomi™ Collaborate To Bring Viewers "Between", A New Premium Original Drama Series investment picks
2014/9/19
Sam Edelman now has a Los Angeles area address.
Sign-up for Sam Edelman Expands to West Coast investment picks
2014/10/14
Parsley Energy, Inc. (NYSE: PE) (“the Company”) plans to release its third quarter 2014 financial and operating results after the market closes on Tuesday, November 11, 2014.
Sign-up for Parsley Energy Schedules Third Quarter 2014 Earnings Conference Call for November 12, 2014 investment picks
VANCOUVER, Wash.
Sign-up for Papa Murphy's and Udi's Gluten Free Announce New Partnership investment picks
Pier 1 Imports, Inc. (NYSE:PIR) today reported financial results for the second quarter ended August 30, 2014.
Sign-up for Pier 1 Imports, Inc. Reports Fiscal 2015 Second Quarter Results; Revises Full Year Financial Guidance; Provides Roadmap for Omni-Channel Business and Intermediate-Term Financial Goals investment picks
RICHMOND, Va.
Sign-up for Brink's To Restructure Netherlands Operations investment picks
First time in history a technology receives FDA approval and proposed national coverage by CMS on the same day Screening test detects 92% of colorectal cancer MADISON, Wis.
Sign-up for FDA Approves Exact Sciences' Cologuard®; First and Only Stool DNA Noninvasive Colorectal Cancer Screening Test investment picks
BEDFORD, Texas , Aug.
Sign-up for Galenfeha, Inc. Announces Clearance for DTCC Eligibility investment picks
2014/9/17
Leasing company adds six 787-9s and five 737 MAX 9s to portfolio SEATTLE , Sept.
Sign-up for Boeing, Avolon Finalize Order for 787 Dreamliners, 737 MAXs investment picks
2014/10/15
Introducing Nexus 6 from Google and Motorola: More Android.
Sign-up for Introducing Nexus 6 from Google and Motorola: More Android. More screen. More everything. investment picks
VALENCIA, Calif., Sept.
Sign-up for MannKind Announces Closing of Global Licensing Agreement With Sanofi investment picks
2014/9/12
By David Weidner, MarketWatch SAN FRANCISCO (MarketWatch) -- Around early 2004, Apple Inc. executives were in a strategy meeting when they began to complain about their cellular phones.
Sign-up for An Apple iBank is only a matter of time investment picks
* Net Revenue of $131.8 million, growing 17.5% year-over-year in USD, 65.9% in local currencies BUENOS AIRES, Argentina, Aug.
Sign-up for MercadoLibre, Inc. Reports Financial Results for Second Quarter 2014 investment picks
2014/10/10
By Andria Cheng, MarketWatch NEW YORK (MarketWatch)--Family Dollar Stores Inc. delivered another disappointing result late Thursday and said this quarter will be its most challenging in the new fiscal year.
Sign-up for UPDATE: Family Dollar's shares still cushioned by merger hope investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Popular Articles From: Tokai Pharmaceuticals Announces Updated Phase 2 Data on Galeterone in Patients with Advanced Prostate Cancer to be Presented at the ESMO 2014 Congress to UPDATE: Family Dollar's shares still cushioned by merger hope
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent